NCT06630260 2026-01-215G-RUBYInstitute of Cancer Research, United KingdomPhase 1/2 Recruiting182 enrolled
NCT05798507 2025-12-15Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With GlioblastomaEmory UniversityPhase EARLY_PHASE1 Active not recruiting14 enrolled